Vol 1: Cardiology Diagnostics | Vol 2: Hospital-based Diagnostics | Vol 3: Physician-based Diagnostics | Vol 4: Infectious Diseases Diagnostics
A complete and practical analysis packed with facts, figures, forecasts and product/competitive assessments
Critical analysis and 5-year forecasts of key point-of-care diagnostic technologies, their prospects and the companies driving change and innovation.
The In Vitro diagnostics market was worth approximately US$43 billion in 2011 and grew approximately 4% compared with 2010. The Point-of-Care (POC) sector represents 35% of the overall market and was valued at US$15.1 billion in 2011.
The products covered in this report include those used by healthcare professionals and self-testers, which accounted for 33% of the POC sector, and consumer POC products which represented 7%. The remaining 60% of sales comes from blood glucose monitoring products.
The POC sector is growing faster than the overall IVD market. During 2011, growth in the POC sector, excluding consumer and glucose testing products, is estimated to have been 7%. Growth was driven by the increasing adoption of all types of POC technologies by both professional and self-testing users, as well as the launch of new products and rising demand in emerging markets.
POC Diagnostics is a sector on the move. Key reasons why it is interesting:
POC diagnostics play a key role in the diagnosis and monitoring of acute and chronic illnesses, the detection of some types of cancer and infectious diseases, and for general blood and urine testing. It can also play a role in preventative medicine, which is intended to help curb the increasing incidence of chronic conditions such as diabetes and cardiovascular disease through early detection and the identification of patients with risk factors.
POC testing offers clear benefits over laboratory testing. As it is conducted near the patient, results are available more quickly, enabling healthcare providers to act swiftly to emergencies such as heart attack and provide a diagnosis while the patient is still in the healthcare facility, speeding treatment and reducing visits to the doctor. For patients, self-testing helps users control effectively their condition which lowers the time and cost of treating complications, and the need for them to regularly see their doctor.
The POC diagnostics market is dominated by well-established and accepted product areas such as infectious disease and pregnancy testing. However, there is major growth potential for the adoption of POC technologies in settings such as hospital emergency, critical care and out-patient departments and areas without access to central labs.
This report collection delivers a complete and insightful analysis The four volumes of this report collection, originally published Autumn 2012/Spring 2013, make a fascinating and detailed appraisal of this fast-growing sector of the diagnostics industry worldwide. Whatever your interest, the report will provide a one-stop assessment of opportunities and challenges going forward.
Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/168908
A special collection of insightful management reports available as a discounted set:
Vol 1: Cardiology Diagnostics
Vol 2: Hospital-based Diagnostics
Vol 3: Physician-based Diagnostics
Vol 4: Infectious Diseases Diagnostics
Use this extensive 4-volume report to...
Understand the trends which are shaping the sector’s operation
Identify which sectors offer the greatest growth potential over the next 5 years
Highlight the emerging companies in the industry with novel technology
Evaluate the competitive landscape and identify the companies to watch
Know who’s striking strategic and tactical partnerships
Monitor M&A activity and the changing competitive landscape